Bryostatin-1 synergizes with histone deacetylase inhibitors to reactivate HIV-1 from latency

Current HIV Research
Moisés PérezEduardo Muñoz

Abstract

The persistence of latent HIV-infected cellular reservoirs represents the major hurdle to virus eradication on patients treated with HAART. It has been suggested that successful depletion of such latent reservoirs will require a combination of therapeutic agents that can specifically and efficiently act on cells harboring latent HIV-1 provirus. Using Jurkat-LAT-GFP cells, a tractable model of HIV-1 latency, we have found that bryostatin -1 reactivates HIV-1 through a classical PKC-dependent pathway. Bryostatin-1 also activates MAPKs and NF-κB pathways and synergizes with HDAC inhibitors to reactivate HIV-1 from latency. Bryostatin-1 downregulates the expression of the HIV-1 co-receptors CD4 and CXCR4 and prevented de novo HIV-1 infection in susceptible cells. We applied proteomic methods to investigate major changes in protein expression in Jurkat-LAT-GFP under latency and reactivation conditions. We identified up-regulation of proteins that may be involved in the innate anti-HIV-1 response (NKEF-A and MHD2) and in different cell functions (i.e. cofilin-1 and transgelin-2) of the host cells. PKC agonists may represent a valuable pharmacological approach to purge latent HIV from cellular reservoirs and at the moment, the only cl...Continue Reading

Citations

Mar 15, 2012·Current HIV/AIDS Reports·Alain Lafeuillade
Apr 2, 2013·Lancet·Christine KatlamaRafick P Sekaly
Jul 13, 2013·Cell Death & Disease·A D BadleyS R Lewin
Nov 16, 2011·Immunology and Cell Biology·Fiona WightmanSharon R Lewin
Feb 15, 2011·AIDS Research and Human Retroviruses·David M Margolis
Jul 24, 2012·Nucleic Acids Research·Koh FujinagaB Matija Peterlin
Jan 19, 2011·Current Opinion in HIV and AIDS·David M Margolis
Jun 28, 2013·Retrovirology·Carine Van LintAlessandro Marcello
Apr 13, 2011·PloS One·Michael KovochichJerome A Zack
Feb 25, 2014·Current Infectious Disease Reports·David M Margolis
Apr 17, 2014·Viruses·Angela Battistini, Marco Sgarbanti
Mar 1, 2013·Current Opinion in HIV and AIDS·David M Margolis, Daria J Hazuda
Jan 6, 2016·The Journal of Clinical Investigation·Daniele C CaryB Matija Peterlin
Jul 7, 2012·Cytokine & Growth Factor Reviews·Anna Lisa RemoliMarco Sgarbanti
Sep 11, 2014·Journal of the American Chemical Society·Matthew B KraftGary E Keck
Oct 14, 2014·Virology·Jeffrey P MurryJohn A T Young
Oct 3, 2015·Antiviral Research·Marta Martínez-BonetMaria Ángeles Muñoz-Fernández
Jul 23, 2015·Scientific Reports·Laura DíazMa Ángeles Muñoz-Fernández
Mar 23, 2012·Immunological Reviews·Jonathan K Chan, Warner C Greene
Nov 22, 2015·BMC Medicine·Chao LiuHui Zhang
Nov 14, 2015·Scientific Reports·Marta Martínez-BonetMaria Ángeles Muñoz-Fernández
Mar 19, 2014·Virology·Caroline P Passaes, Asier Sáez-Cirión
May 15, 2015·Natural Product Reports·Erik M LarsenRichard E Taylor
Apr 9, 2013·Human Vaccines & Immunotherapeutics·Thomas A RasmussenOle S Søgaard
Jul 3, 2013·Current Opinion in Virology·Marco Sgarbanti, Angela Battistini
Nov 19, 2013·Cell·Debbie S Ruelas, Warner C Greene
Jun 1, 2014·Biochemical and Biophysical Research Communications·Xiaoli ZhuHuanzhang Zhu
Oct 3, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stephen T SmileyJeffrey S Rice
Apr 14, 2012·Advances in Virology·Lisa N McKernanJoseph Kulkosky
Jun 3, 2016·PLoS Pathogens·Mohamed Abdel-MohsenSatish K Pillai
Jun 24, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ti MengYalin Dong
Apr 26, 2018·Journal of Cellular Biochemistry·Tapan K Khan, Thomas J Nelson
Dec 21, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Clélia DentalMichel J Tremblay
Dec 12, 2017·AIDS Research and Human Retroviruses·Daniele C Cary, B Matija Peterlin
Sep 21, 2013·Journal of Virology·Benjamin TrinitéDavid N Levy
Jun 16, 2016·F1000Research·Daniele C Cary, B Matija Peterlin
Oct 21, 2015·Nature Communications·Amarendra PeguGary J Nabel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.